One in 37 type 2 diabetics taking a commonly prescribed drug will have a heart attack

A study by Northwestern University found that sulfonylureas and basal insulin - which are given to patients if metformin fails - make them more at risk than the newer drug class DPP-4 inhibitors.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news